MDR1 haplotypes modify BEN disease risk: A study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls

Nephron - Experimental Nephrology

Volumn 96, Issue 1, 2004, Pages

  Atanasova, S ^a   Von Ahsen, N ^b   Dimitrov, T ^a   Armstrong, V ^b   Oellerich, M ^b   Toncheva, D ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Balkan endemic nephropathy; Bulgarian population; Haplotyping; MDR1; SNP analysis

Indexed keywords

ADULT; AGED; ARTICLE; BULGARIA; CONTROLLED STUDY; DETOXIFICATION; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HEREDITY; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MDR 1 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; XENOBIOTIC METABOLISM; GENETIC ANALYSIS; GENETIC POLYMORPHISM;

BALKAN NEPHROPATHY; BULGARIA; CASE-CONTROL STUDIES; FEMALE; GENES, MDR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE DETECTION; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; SEX DISTRIBUTION;

MULTIDRUG RESISTANCE PROTEIN 1;

EID: 1842611586     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075571     Document Type: Article

References (32)

1. Sattler T, Dimitrov T, Hall P: Relation between endemic (Balkan) nephropathy and urinary tract tumors. Lancet 1977;i:278.
2. Dimitrov T: Balkan endemic nephropathy in Bulgaria. Facta Universitatis 2002;9:7-14.
3. Bozić Z, Duancić V, Belicza M, Kraus O, Skliarov I: Balkan endemic nephropathy: Still mysterious disease. Eur J Epidemiol 1995;11:235-238.
4. Polenaković M, Stefanović V: Balkan nephropathy; in Davison A, Cameron J, Grunfeld J, Kerr D, Winerals G (eds): Oxford Textbook of Clinical Nephrology, ed 2. Oxford, Oxford University Press, 1997, vol 2, pp 1203-1211.
5. Mihailov T: New phenomena in the genealogical study of Balkan endemic nephropathy in Bulgaria; in Strahinjić S, Stefanović V (eds): Endemic (Balkan) nephropathy. Nis, University Press, 1979, pp 253-258.
6. Toncheva D, Dimitrov T, Stoyanova S: Etiology of Balkan endemic nephropathy: A multifactor disease. Eur J Epidemiol 1998;14:389-394.
7. Radovanović Z, Sindić M, Polenaković M, Dukanović L, Petronić V (eds): Endemic Nephropathy. Belgrad, Zavod za Udzbenike I Nastavna Sredstva, 2000, pp 1-200.
8. Stefanović V: Balkan endemic nephropathy: A need for novel aetiological approaches. Q J Med 1998;91:457-463.
9. Toncheva D, Dimitrov T: Genetic predisposition to Balkan endemic nephropathy. Nephron 1996;72:564-569.
10. Ernest S, Rajaraman S, Megyesi J, Bello-Reuss EN: Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron 1997;77:284-289.
11. Sylvain E, Rajaraman S, Megyesi J, Bello-Reuss E: Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron 1997;77:284-289.
12. Schinkel AH: The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 1997;8:161-170.
13. Inui KI, Masuda S, Saito H: Cellular and molecular aspects of drug transport in the kidney. Kidney Int 2000;58:944-958.
14. Yeh GC, Lopaczynska J, Poore CM, Phang JM: A new functional role for P-glycoprotein: Efflux pump for benzo(α)pyrene in human breast cancer MCF-7 cells. Cancer Res 1992;52:6692-6695.
15. Fardel O, Lecureur V, Guillouzo A: The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-1291.
16. Chin KV, Tanaka S, Darlington G, Pastan I, Gottesman MM: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 1990;265:221-226.
17. Orem WH, Feder GL, Finkelnman RB: A possible link between Balkan endemic nephropathy and the leaching of toxic organic compounds from Pliocene lignites by groundwater. Int J Coal Geol 1999;40:3237-3252.
18. Voice T, McElmurry S, Long D, Petropoulos E, Ganev V: Evaluation of coal leachate contamination of water supplies as a hypothesis for the occurrence of Balkan endemic nephropathy in Bulgaria. Facta Universitatis Med Biol 2002;9:123-130.
19. Wedeen P: Environmental renal disease: Lead, cadmium and Balkan endemic nephropathy. Kidney Int 1991;34(suppl):4-8.
20. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR: Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001;70:189-199.
21. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-3478.
22. Johne A, Köpke K, Gerloff T, Mai I, Rietbrock S, Meisel C, Hoffmeyer S, Kerb R, Fromm M, Brinkmann U, Eichelbaum M, Brockmöller, Cascorbi I, Roots I: Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 2002;72:584-594.
23. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H: Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002;13:1847-1854.
24. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. von Ahsen N, Richter M, Grupp C, Ringe B, Oellerich M, Armstrong VW: No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem 2001;47:1048-1052.
26. von Ahsen N, Oellerich M, Armstrong VW, Schutz E: Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: Prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. Clin Chem 1999;45:2094-2101.
27. Terwillinger J, Ott J: Handbook of Human Genetic Linkage. Baltimore, Johns Hopkins University Press, 1994.
28. Xie X, Ott J: Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993;53:1107.
29. Zhao H, Curtis D, Sham C: Model-free analysis and permutation test for allelic associations. Hum Hered 2000;50:133-139.
30. Bland JM, Altman D: The odds ratio. BMJ 2000;320:1468.
31. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A, Ohdo S, Ohtani H, Sawada Y, Higuchi S, Otsubo K: Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 2002;72:209-219.
32. Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: Hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics 2001;2:51-64.